LYFAX
ETF
LYFAX
·
UNKNOWN
·
60 holdings
$16.03
▲
$0.21
(1.33%)
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—
About LYFAX
No description available for this ETF.
Fund Details
- Expense Ratio
- —
- Inception Date
- —
- Prev. Close
- $15.82
- Exchange
- UNKNOWN
- Currency
- USD
- Holdings As Of
- Apr 10, 2026
- Tracked Holdings
- 83.3%
- HHI Score
- 258.40
- Top Sector
- Healthcare (78.496653%)
Performance
Moderate (23.8%)
↗ Accelerating
1W
▲ 1.89%
1M
▲ 1.38%
3M
▲ 2.93%
6M
▲ 20.96%
YTD
▲ 2.28%
1Y
▲ 35.80%
3Y
▲ 21.69%
1W return (+1.89%) exceeds 1M (+1.38%) — momentum is building
Price History
Concentration Risk
41.03%
Moderately Concentrated
Diversified
Concentrated
The top 10 holdings represent 41.03% of the fund. A moderate concentration level — the fund balances top holdings with broader diversification.
Top Holdings Today
GILD
▼ -2.18%
VRTX
▼ -2.34%
IONS
▼ -1.65%
INCY
▼ -0.92%
INSM
▼ -3.00%
ARGX
▼ -0.11%
AXSM
▼ -0.44%
NBIX
▼ -2.09%
ROIV
▼ -0.96%
Weighted avg. of top holdings
▼ -1.67%
Sector Allocation
Healthcare
78.50%
Top 10 Holdings
GILD
Gilead Sciences Inc.
VRTX
Vertex Pharmaceuticals Incorporated
AstraZeneca PLC
AstraZeneca PLC
IONS
Ionis Pharmaceuticals, Inc.
INCY
Incyte Corporation.
INSM
Insmed Inc
ARGX
Argenx SE
AXSM
Axsome Therapeutics Inc.
NBIX
Neurocrine Biosciences Inc
ROIV
Roivant Sciences Ltd
Other positions
All Holdings (60)
Top 10: 41.03% of fund| # | Ticker | Name | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | GILD | Gilead Sciences Inc. | 7.21% | 21,761 | 2.67 M |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 5.71% | 4,663 | 2.11 M |
| 3 | AstraZeneca PLC | AstraZeneca PLC | 5.28% | 21,243 | 1.95 M |
| 4 | IONS | Ionis Pharmaceuticals, Inc. | 3.96% | 18,523 | 1.47 M |
| 5 | INCY | Incyte Corporation. | 3.59% | 13,471 | 1.33 M |
| 6 | INSM | Insmed Inc | 3.57% | 7,588 | 1.32 M |
| 7 | ARGX | Argenx SE | 3.24% | 1,425 | 1.20 M |
| 8 | AXSM | Axsome Therapeutics Inc. | 3.00% | 6,088 | 1.11 M |
| 9 | NBIX | Neurocrine Biosciences Inc | 2.83% | 7,383 | 1.05 M |
| 10 | ROIV | Roivant Sciences Ltd | 2.64% | 45,076 | 978,149.2 |
Showing top 10 of 60 holdings
·
Listed: 93.62%
·
6.38% in other positions
Related ETFs
{"event":"ticker_viewed","properties":{"ticker":"LYFAX","listing_kind":"etf","pathname":"/etfs/lyfax","exchange":"UNKNOWN"}}